May 27th，The National Development and Reform Commission issued the "Notice on Special Inspection of Pharmaceutical Price in the Count，The raw medicine is the key inspection object，Yesterday，The results of the penalty of the Development and Reform Commission came out，Three companies were severely fined more than 260,000。

 

  Although from the report,，The price after the final rising is only 1 grid，The price is still very low，But the behavior of its price increase is illegal，I can only accept the fine。

 

  The National Development and Reform Commission has recently been in China、Shandong Xinyi、Three companies including Changzhou Four Medicine reached and implemented Azimazo Lenzan、Penalties of tablets monopoly agreement，Total fines of more than 2.6 million yuan。

 

  Monopoly details

 

  Aiszzoleon has sedation、Hypnosis and anti -anxiety curative effect，is the second type of psychiatric drugs strictly controlled by the country，Aiszzzzone Tablets belong to the nervous system medicine Stake Sports Bettingstake betting appin the national basic drug catalog，At the same time, it is included in the national low -cost medicine directory。my country's admission and production of second -class psychotropic drugs and production strict control，There are only 4 companies that have obtained the production approval of Aiszolun Materials Pharmaceuticals in the country，Actually only Chinese Pharmaceuticals、Shandong Xinyi and Changzhou Four Medicine，These 3 companies are also manufacturers of Aiszoleline tablets。

 

  Investigation discovery，After the promulgation of the low -cost drug policy in 2014，3 companies pass the meeting、Meeting、Phone、SMS、Email and other methods，Reached and implemented a monopoly protocol for joint resistance in the AIzzoleon Materials Pharmaceutical Market，A monopoly protocol for fixed or changing the price of commodity in the market in the AIzzolun tablets。From September to October 2014，The party holds a meeting in Zhengzhou, Henan，Consultation of the relevant arrangements of Aiszolun ingredients and tablets。

 

  The party finally reached the following consensus: First, the Azimzolun raw medicine produced by each company is only for the use of the company's production doses，No longer exported; the second is to form a tacit understanding of the collective price increase on the collective price increase of Aiszolun tablets。Since December 2014，Three companies gradually increase the price of Aiszolun tablets through the form of a price adjustment letter，China Traditional Chinese Medicine and Shandong Xinyi have passed the meeting many times、Phone、SMS and other forms to communicate with price adjustment information。

 

  Tablets rose to 1 grown/1 tablet

 

  The retrieved raw medicine sales data display，2013 to 2014，The parties supply the raw medicine for 16 tablets production enterprises in the lower reaches。After My stake betting appstake betting appOctober 2014，The parties have stopped normal supply，The raw medicine produced is for self -use，Most tablets manufacturers are forced to discontinue production due to lack of raw materials。

 

  Sales data of the retrieved tablets，From December 2014 to the present，The prices of Aiszolun tablets sold by 3 companies have risen sharply，The price increase is consistent，Prove that the price monopoly agreement of the joint price increase has been substantially implemented。Eliramine tablets with 1mg*20 specifications produced by 3 companies as examples，2015 to the present，China Traditional Chinese Medicine's factory price rose more than 3 times，Shandong Xinyi rose nearly 2 times，Changzhou Four Medicine rose 1.6 times，The ex -factory price of Aiszzzzzzzzone's factory from 3 companies rose to about 1 cents/tablet。

 

  Huazhong Pharmaceutical、Shandong Xinyi、Changzhou Four Medicine as an independent market subject for the production and sale of Azimzoleon and tablets，It belongs to the market in Aiszolelun、Aiszzolen tablets market has a competitive relationship with operators。The party reached and implemented by the parties combined with the monopoly protocol of the transaction，Make other tablets manufacturers forced to withdraw from the market due to lack of key investment，Serious exclusion、Limit the competition in the tablet market，It also cleared the obstacle to implementing joint prices in the tablet market。

 

  Monopoly Against Against Against Against Against Price Agent Aponeon Tablet Price Agent，Directly leading to a significant increase in the price of Aiszolon tablets since 2015，Added the burden of medication for the majority of patients，It harmed the interests of consumers。Under the common role of two monopoly protocols，Aiszoleline tablets decreased in total supply，Patient's medication can be affected by sex。

 

  Stake Sports Bettingstake online sports bettingDifferent fines of three fines

 

  According to the nature of the monopoly behavior、degree、Duke time，and the different role of the parties in the monopoly agreement、The degree of coordination of the survey，The National Development Commission ordered the parties to stop implementing the monopoly agreement，and a fine of 2603823 yuan。

 

  Where，Reach to the monopoly protocol、During the implementation process, the dominant role，In 2015, the sales of 7 percent of the sales of Aiszizilon tablets，counting 1571829 yuan;

 

  Participants of the monopoly protocol、During the investigation process, Shandong Xinyi, which cooperates with the administrative organs to investigate and deal with illegal acts and perform meritorious performance，In 2015, the sales of Aiszizilon tablets at 2.5 % of the sales，counting 547563 yuan;

 

  followers of the monopoly protocol、Changzhou Four Medicine, which is lighter and can actively rectify，At 3 percent of the sales of Aiszizilon in 2015，484431 yuan。

 

  The National Development and Reform Commission has recently issued the "Notice on Special Inspection of Pharmaceutical Price Inspection in the country" (issuing price -to -price supervision [2016] No. 1101，Key check the price of abnormal fluctuations in the key inspection price、Drug varieties，Concentration forces to solve the problem of strong reflection of the masses and enterprises，Effectively maintain the fair competition order of the pharmaceutical market，Protect the legitimate rights and interests of the majority of patients。Welcome all sectors of society to via 12358 price supervision platform，Participate in regulating drug price behavior。

 

  Attachment: 7 major priorities of the State Development and Reform Commission's prices:

 

  (1) APR、Drug production and operation enterprises reached、behavior of implementing monopoly protocols，Industry Association organized production and operation enterprises to reach、Acts in implementing a monopoly agreement;

 

  (2) APIP、Drug production and operation enterprises abuse market dominance，My stake betting appSelling My stake betting appraw medicine for unfair high price、Drug behavior;

 

  (3) Social retail enterprise fictional original price、misleading price marks and other price fraud behavior;

 

  (4) Medical institutions do not perform government pricing drugs zero difference rate、The behavior of the price increase rate policy;

 

  (5) Government pricing drugs break through the government's maximum ex -factory (retail) price sales;

 

  (6) Do not execute the yard price in accordance with regulations、Price publicity system behavior;

 

  (7) Other violations of the Price Law、Anti -Monopoly Law behavior。